Patient Characteristics
. | Autologous (%) . | Unrelated (%) . | P . |
---|---|---|---|
Total | 214 | 337 | |
Sex | |||
Male | 142 (66) | 203 (60) | .15 |
Female | 72 (34) | 134 (40) | |
Age | |||
0-18 yrs | 160 (75) | 216 (64) | .009 |
19+ yrs | 54 (25) | 121 (36) | |
Remission No. | |||
1* | 51 (23.8) | 52 (15.6) | <.001 |
[18% ≤ 18; 6% > 18] | [9% ≤ 18; 7% > 18] | ||
2 | 98 (45.8) | 106 (31.7) | |
[35% ≤ 18; 11% > 18] | [24% ≤ 18; 7% > 18] | ||
3+ | 53 (24.8) [18% ≤ 18; 7% > 18] | 93 (27.8) [21% ≤ 18; 7% > 18] | |
Relapse† | 12 (5.6) | 83 (24.9) | |
[5% ≤ 18; 1% > 18] | [10% ≤ 18; 14% > 18] | ||
Year of BMT | |||
1987-1990 | 142 (66.4) | 94 (27.9) | <.001 |
1991-1993 | 72 (33.6) | 243 (72.1) | |
Conditioning Regimen‡ | |||
Cy + TBI | 37 (17.3) | 125 (37) | <.001 |
Cy + TBI + other drugs | 170 (79.4) | 183 (54) | |
Chemotherapy without TBI | 7 (3.3) | 29 (9) |
. | Autologous (%) . | Unrelated (%) . | P . |
---|---|---|---|
Total | 214 | 337 | |
Sex | |||
Male | 142 (66) | 203 (60) | .15 |
Female | 72 (34) | 134 (40) | |
Age | |||
0-18 yrs | 160 (75) | 216 (64) | .009 |
19+ yrs | 54 (25) | 121 (36) | |
Remission No. | |||
1* | 51 (23.8) | 52 (15.6) | <.001 |
[18% ≤ 18; 6% > 18] | [9% ≤ 18; 7% > 18] | ||
2 | 98 (45.8) | 106 (31.7) | |
[35% ≤ 18; 11% > 18] | [24% ≤ 18; 7% > 18] | ||
3+ | 53 (24.8) [18% ≤ 18; 7% > 18] | 93 (27.8) [21% ≤ 18; 7% > 18] | |
Relapse† | 12 (5.6) | 83 (24.9) | |
[5% ≤ 18; 1% > 18] | [10% ≤ 18; 14% > 18] | ||
Year of BMT | |||
1987-1990 | 142 (66.4) | 94 (27.9) | <.001 |
1991-1993 | 72 (33.6) | 243 (72.1) | |
Conditioning Regimen‡ | |||
Cy + TBI | 37 (17.3) | 125 (37) | <.001 |
Cy + TBI + other drugs | 170 (79.4) | 183 (54) | |
Chemotherapy without TBI | 7 (3.3) | 29 (9) |